American Healthcare REIT, Inc.
AHRdata completeness 75%11 fiscal years on fileData notes: no data for concept 'totalDebt'
American Healthcare REIT, Inc. earns about 3% on invested capital, but has diluted owners by 233% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $1.12B1 | $1.41B2 | $1.67B3 | $1.88B3 | $2.09B3 |
| Net income | −$47.8M4 | −$81.3M5 | −$71.5M6 | −$37.8M6 | $69.8M6 |
| Operating cash flow | $17.9M7 | $147.8M8 | $98.5M9 | $176.1M9 | $294.4M9 |
| Capital expenditure | — | $7.54M10 | — | — | — |
| Free cash flow (derived) | — | $140.2M8 | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $81.6M11 | $65.1M12 | $43.4M12 | $76.7M12 | $114.8M12 |
| Diluted shares | 50.1M | 65.8M | 66.0M | 130.6M | 166.8M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $199.02 of net worth that earned you $4.18 last year.
It earned an average 3% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 233% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001632970-24-000039 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001632970-25-000018 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-082692 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001632970-24-000039 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001632970-25-000018 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-082692 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001632970-24-000039 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001632970-25-000018 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-082692 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001632970-23-000029 (PaymentsForCapitalImprovements)
- 10-K · period ending 2021-12-31 · accession 0001632970-25-000018 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001193125-26-082692 (CashAndCashEquivalentsAtCarryingValue)